Copyright Reports & Markets. All rights reserved.

Global Intravenous Iron Drugs Market Research Report 2021

Request for Sample of this report
Buy now

1 Intravenous Iron Drugs Market Overview

  • 1.1 Product Overview and Scope of Intravenous Iron Drugs
  • 1.2 Intravenous Iron Drugs Segment by Type
    • 1.2.1 Global Intravenous Iron Drugs Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Ferric Gluconate
    • 1.2.3 Ferric Carboxymaltose
    • 1.2.4 Iron Sucrose
    • 1.2.5 Iron Dextran
  • 1.3 Intravenous Iron Drugs Segment by Application
    • 1.3.1 Intravenous Iron Drugs Sales Comparison by Application: (2021-2027)
    • 1.3.2 Nephrology
    • 1.3.3 Gynecology & Obstetrics
    • 1.3.4 Gastroenterology
    • 1.3.5 Oncology
    • 1.3.6 Cardiology
    • 1.3.7 Others
  • 1.4 Global Intravenous Iron Drugs Market Size Estimates and Forecasts
    • 1.4.1 Global Intravenous Iron Drugs Revenue 2016-2027
    • 1.4.2 Global Intravenous Iron Drugs Sales 2016-2027
    • 1.4.3 Intravenous Iron Drugs Market Size by Region: 2016 Versus 2021 Versus 2027

2 Intravenous Iron Drugs Market Competition by Manufacturers

  • 2.1 Global Intravenous Iron Drugs Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Intravenous Iron Drugs Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Intravenous Iron Drugs Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Intravenous Iron Drugs Manufacturing Sites, Area Served, Product Type
  • 2.5 Intravenous Iron Drugs Market Competitive Situation and Trends
    • 2.5.1 Intravenous Iron Drugs Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Intravenous Iron Drugs Players Market Share by Revenue
    • 2.5.3 Global Intravenous Iron Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Intravenous Iron Drugs Retrospective Market Scenario by Region

  • 3.1 Global Intravenous Iron Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Intravenous Iron Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Intravenous Iron Drugs Market Facts & Figures by Country
    • 3.3.1 North America Intravenous Iron Drugs Sales by Country
    • 3.3.2 North America Intravenous Iron Drugs Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Intravenous Iron Drugs Market Facts & Figures by Country
    • 3.4.1 Europe Intravenous Iron Drugs Sales by Country
    • 3.4.2 Europe Intravenous Iron Drugs Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Intravenous Iron Drugs Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Intravenous Iron Drugs Sales by Region
    • 3.5.2 Asia Pacific Intravenous Iron Drugs Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Intravenous Iron Drugs Market Facts & Figures by Country
    • 3.6.1 Latin America Intravenous Iron Drugs Sales by Country
    • 3.6.2 Latin America Intravenous Iron Drugs Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Intravenous Iron Drugs Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Intravenous Iron Drugs Sales by Country
    • 3.7.2 Middle East and Africa Intravenous Iron Drugs Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 U.A.E

4 Global Intravenous Iron Drugs Historic Market Analysis by Type

  • 4.1 Global Intravenous Iron Drugs Sales Market Share by Type (2016-2021)
  • 4.2 Global Intravenous Iron Drugs Revenue Market Share by Type (2016-2021)
  • 4.3 Global Intravenous Iron Drugs Price by Type (2016-2021)

5 Global Intravenous Iron Drugs Historic Market Analysis by Application

  • 5.1 Global Intravenous Iron Drugs Sales Market Share by Application (2016-2021)
  • 5.2 Global Intravenous Iron Drugs Revenue Market Share by Application (2016-2021)
  • 5.3 Global Intravenous Iron Drugs Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Allergan
    • 6.1.1 Allergan Corporation Information
    • 6.1.2 Allergan Description and Business Overview
    • 6.1.3 Allergan Intravenous Iron Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Allergan Product Portfolio
    • 6.1.5 Allergan Recent Developments/Updates
  • 6.2 AMAG Pharmaceuticals
    • 6.2.1 AMAG Pharmaceuticals Corporation Information
    • 6.2.2 AMAG Pharmaceuticals Description and Business Overview
    • 6.2.3 AMAG Pharmaceuticals Intravenous Iron Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 AMAG Pharmaceuticals Product Portfolio
    • 6.2.5 AMAG Pharmaceuticals Recent Developments/Updates
  • 6.3 Daiichi Sankyo
    • 6.3.1 Daiichi Sankyo Corporation Information
    • 6.3.2 Daiichi Sankyo Description and Business Overview
    • 6.3.3 Daiichi Sankyo Intravenous Iron Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Daiichi Sankyo Product Portfolio
    • 6.3.5 Daiichi Sankyo Recent Developments/Updates
  • 6.4 Galenica
    • 6.4.1 Galenica Corporation Information
    • 6.4.2 Galenica Description and Business Overview
    • 6.4.3 Galenica Intravenous Iron Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Galenica Product Portfolio
    • 6.4.5 Galenica Recent Developments/Updates
  • 6.5 Pharmacosmos
    • 6.5.1 Pharmacosmos Corporation Information
    • 6.5.2 Pharmacosmos Description and Business Overview
    • 6.5.3 Pharmacosmos Intravenous Iron Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Pharmacosmos Product Portfolio
    • 6.5.5 Pharmacosmos Recent Developments/Updates
  • 6.6 Nippon Shinyaku
    • 6.6.1 Nippon Shinyaku Corporation Information
    • 6.6.2 Nippon Shinyaku Description and Business Overview
    • 6.6.3 Nippon Shinyaku Intravenous Iron Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Nippon Shinyaku Product Portfolio
    • 6.6.5 Nippon Shinyaku Recent Developments/Updates
  • 6.7 NOXXON Pharma
    • 6.6.1 NOXXON Pharma Corporation Information
    • 6.6.2 NOXXON Pharma Description and Business Overview
    • 6.6.3 NOXXON Pharma Intravenous Iron Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 NOXXON Pharma Product Portfolio
    • 6.7.5 NOXXON Pharma Recent Developments/Updates
  • 6.8 Rockwell Medical
    • 6.8.1 Rockwell Medical Corporation Information
    • 6.8.2 Rockwell Medical Description and Business Overview
    • 6.8.3 Rockwell Medical Intravenous Iron Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Rockwell Medical Product Portfolio
    • 6.8.5 Rockwell Medical Recent Developments/Updates
  • 6.9 Sanofi
    • 6.9.1 Sanofi Corporation Information
    • 6.9.2 Sanofi Description and Business Overview
    • 6.9.3 Sanofi Intravenous Iron Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Sanofi Product Portfolio
    • 6.9.5 Sanofi Recent Developments/Updates
  • 6.10 Wanbang Biopharmaceutical
    • 6.10.1 Wanbang Biopharmaceutical Corporation Information
    • 6.10.2 Wanbang Biopharmaceutical Description and Business Overview
    • 6.10.3 Wanbang Biopharmaceutical Intravenous Iron Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Wanbang Biopharmaceutical Product Portfolio
    • 6.10.5 Wanbang Biopharmaceutical Recent Developments/Updates

7 Intravenous Iron Drugs Manufacturing Cost Analysis

  • 7.1 Intravenous Iron Drugs Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Intravenous Iron Drugs
  • 7.4 Intravenous Iron Drugs Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Intravenous Iron Drugs Distributors List
  • 8.3 Intravenous Iron Drugs Customers

9 Intravenous Iron Drugs Market Dynamics

  • 9.1 Intravenous Iron Drugs Industry Trends
  • 9.2 Intravenous Iron Drugs Growth Drivers
  • 9.3 Intravenous Iron Drugs Market Challenges
  • 9.4 Intravenous Iron Drugs Market Restraints

10 Global Market Forecast

  • 10.1 Intravenous Iron Drugs Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Intravenous Iron Drugs by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Intravenous Iron Drugs by Type (2022-2027)
  • 10.2 Intravenous Iron Drugs Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Intravenous Iron Drugs by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Intravenous Iron Drugs by Application (2022-2027)
  • 10.3 Intravenous Iron Drugs Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Intravenous Iron Drugs by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Intravenous Iron Drugs by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Ferric Gluconate
    Ferric Carboxymaltose
    Iron Sucrose
    Iron Dextran

    Segment by Application
    Nephrology
    Gynecology & Obstetrics
    Gastroenterology
    Oncology
    Cardiology
    Others

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    U.A.E

    By Company
    Allergan
    AMAG Pharmaceuticals
    Daiichi Sankyo
    Galenica
    Pharmacosmos
    Nippon Shinyaku
    NOXXON Pharma
    Rockwell Medical
    Sanofi
    Wanbang Biopharmaceutical

    Buy now